The hypoxia-inducible factor-1 alpha (HIF-1 alpha) activates angiogenesis in response to cellular hypoxia, suggesting a spatial correlation between angiogenesis and tissue hypoxia. Methods: Using digital autoradiography of coinjected F-18-labeled azomycin arabinoside (F-8-FAZA) (assessing regional hypoxia) and a glycosylated RGD-containing peptide (I-125-3-iodo-DTyr(4)-cyclo(-Arg-Gly-Asp-DTyr-Lys(SAA)-), or I-125-Gluco-RGD) (assessing angiogenesis via binding to alpha v beta 3 integrin receptors on endothelial cells) performed on 22 EMT6 tumor xenografts, we investigated the intratumoral spatial distribution of these tracers. We applied a Bayesian bivariate image analysis using the mean tumor-to-muscle ratio as a discriminator, resulting in 4 groups: FAZA high/RGD high (Q1), FAZA low/RGD high (Q2), FAZA low/RGD low (Q3), and FAZA high/RGD low (Q4). In an additional 18 xenografts, the immunohistochemically derived HIF-1 alpha protein distribution was compared with F-18-FAZA autoradiography. Animals were divided into groups breathing either room air or carbogen (95% oxygen, 5% CO2) for 4 In until sacrifice. Results: Under room air conditions, roughly 60% of the tumor surface displayed a spatial coupling of F-18-FAZA and I-125-Gluco-RGD uptake: either high (Q1) or low (Q3) uptake for both tracers, with Q1 indicating spatial association of hypoxia and angiogenesis and Q3 indicating adequate oxygenation without active angiogenesis. However, the remaining approximately 40% of the tumor surface showed discordant F-18-FAZA and I-125-Gluco-RGD uptake, indicating that hypoxia and angiogenesis are not necessarily spatially linked to each other and highlighting substantial intratumoral heterogeneity of the F-18-FAZA and I-125-Gluco-RGD uptake. Although carbogen breathing conditions significantly decreased the mean F-18-FAZA tumor-to-muscle ratio, no significant changes were observed for I-125 -Gluco-RGD, indicating that an acute increase in tumor oxygenation did not influence alpha v beta 3 integrin receptor expression. The HIF-1 alpha-positive (HIFpos tumor cell fraction was not significantly influenced by breathing conditions and covered between 0% and 35% of the total tumor section surface. However, the HIFpos tumor section surface was much smaller than the tumor section surface of increased F-18-FAZA uptake, suggesting that both markers are identifying distinctly different biologic processes associated with hypoxia. Conclusion: The study revealed a substantial spatial discordance of the F-18-FAZA and I-125-Gluco-RGD tumor distribution suggesting that hypoxia and angiogenesis are not necessarily spatially linked in malignancies. These results may prove essential in developing advanced targeted systemic chemotherapeutic approaches (such as combinations of hypoxia-activated cytotoxins and antiangiogenic drugs) for hypoxic tumors.

Intratumoral spatial distribution of hypoxia and angiogenesis assessed by F-18-FAZA and I-125-Gluco-RGD autoradiography / Picchio, M; Beck, R; Haubner, R; Seidl, S; Machulla, Hj; Johnson, Td; Wester, Hj; Reischl, G; Schwaiger, M; Piert, M.. - In: THE JOURNAL OF NUCLEAR MEDICINE. - ISSN 0161-5505. - 49:4(2008), pp. 597-605. [10.2967/jnumed.107.046870]

Intratumoral spatial distribution of hypoxia and angiogenesis assessed by F-18-FAZA and I-125-Gluco-RGD autoradiography

Picchio M;
2008-01-01

Abstract

The hypoxia-inducible factor-1 alpha (HIF-1 alpha) activates angiogenesis in response to cellular hypoxia, suggesting a spatial correlation between angiogenesis and tissue hypoxia. Methods: Using digital autoradiography of coinjected F-18-labeled azomycin arabinoside (F-8-FAZA) (assessing regional hypoxia) and a glycosylated RGD-containing peptide (I-125-3-iodo-DTyr(4)-cyclo(-Arg-Gly-Asp-DTyr-Lys(SAA)-), or I-125-Gluco-RGD) (assessing angiogenesis via binding to alpha v beta 3 integrin receptors on endothelial cells) performed on 22 EMT6 tumor xenografts, we investigated the intratumoral spatial distribution of these tracers. We applied a Bayesian bivariate image analysis using the mean tumor-to-muscle ratio as a discriminator, resulting in 4 groups: FAZA high/RGD high (Q1), FAZA low/RGD high (Q2), FAZA low/RGD low (Q3), and FAZA high/RGD low (Q4). In an additional 18 xenografts, the immunohistochemically derived HIF-1 alpha protein distribution was compared with F-18-FAZA autoradiography. Animals were divided into groups breathing either room air or carbogen (95% oxygen, 5% CO2) for 4 In until sacrifice. Results: Under room air conditions, roughly 60% of the tumor surface displayed a spatial coupling of F-18-FAZA and I-125-Gluco-RGD uptake: either high (Q1) or low (Q3) uptake for both tracers, with Q1 indicating spatial association of hypoxia and angiogenesis and Q3 indicating adequate oxygenation without active angiogenesis. However, the remaining approximately 40% of the tumor surface showed discordant F-18-FAZA and I-125-Gluco-RGD uptake, indicating that hypoxia and angiogenesis are not necessarily spatially linked to each other and highlighting substantial intratumoral heterogeneity of the F-18-FAZA and I-125-Gluco-RGD uptake. Although carbogen breathing conditions significantly decreased the mean F-18-FAZA tumor-to-muscle ratio, no significant changes were observed for I-125 -Gluco-RGD, indicating that an acute increase in tumor oxygenation did not influence alpha v beta 3 integrin receptor expression. The HIF-1 alpha-positive (HIFpos tumor cell fraction was not significantly influenced by breathing conditions and covered between 0% and 35% of the total tumor section surface. However, the HIFpos tumor section surface was much smaller than the tumor section surface of increased F-18-FAZA uptake, suggesting that both markers are identifying distinctly different biologic processes associated with hypoxia. Conclusion: The study revealed a substantial spatial discordance of the F-18-FAZA and I-125-Gluco-RGD tumor distribution suggesting that hypoxia and angiogenesis are not necessarily spatially linked in malignancies. These results may prove essential in developing advanced targeted systemic chemotherapeutic approaches (such as combinations of hypoxia-activated cytotoxins and antiangiogenic drugs) for hypoxic tumors.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/63441
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 34
social impact